by Recent Advances in Bioequivalence Testing: Emerging Technologies
16 Feb, 2026Bioequivalence testing is evolving with AI, advanced imaging, and virtual models that cut study times and costs. The FDA's BEAM system and Dissolvit are leading the shift from human trials to precision science-making generics faster and safer.
READ MORE